These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37397463)

  • 21. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
    Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
    [No Abstract]   [Full Text] [Related]  

  • 22. Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction.
    Blanton H; Yin L; Duong J; Benamar K
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
    Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol as a Potential Treatment for Anxiety Disorders.
    Blessing EM; Steenkamp MM; Manzanares J; Marmar CR
    Neurotherapeutics; 2015 Oct; 12(4):825-36. PubMed ID: 26341731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The therapeutic role of Cannabidiol in mental health: a systematic review.
    Khan R; Naveed S; Mian N; Fida A; Raafey MA; Aedma KK
    J Cannabis Res; 2020 Jan; 2(1):2. PubMed ID: 33526132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 28. The Impact of Cannabidiol on Human Brain Function: A Systematic Review.
    Batalla A; Bos J; Postma A; Bossong MG
    Front Pharmacol; 2020; 11():618184. PubMed ID: 33551817
    [No Abstract]   [Full Text] [Related]  

  • 29. Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus.
    Wanner NM; Colwell M; Drown C; Faulk C
    Environ Mol Mutagen; 2020 Nov; 61(9):890-900. PubMed ID: 32579259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products.
    Tran T; Kavuluru R
    Int J Drug Policy; 2020 Mar; 77():102688. PubMed ID: 32092666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Targets of Cannabidiol in Neurological Disorders.
    Ibeas Bih C; Chen T; Nunn AV; Bazelot M; Dallas M; Whalley BJ
    Neurotherapeutics; 2015 Oct; 12(4):699-730. PubMed ID: 26264914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol and brain function: current knowledge and future perspectives.
    Schouten M; Dalle S; Mantini D; Koppo K
    Front Pharmacol; 2023; 14():1328885. PubMed ID: 38288087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
    Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K
    Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models.
    Shu G; He Y; Suo J; Wu C; Gong X; Xiang Y; Yang W; Cheng J; Wang Y; Chen W; Shen J
    Neurosci Lett; 2024 Mar; 826():137723. PubMed ID: 38467272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Medical Cannabis Treatment for Autistic Children on Anxiety and Restricted and Repetitive Behaviors and Interests: An Open-Label Study.
    David A; Stolar O; Berkovitch M; Kohn E; Hazan A; Waissengreen D; Gal E
    Cannabis Cannabinoid Res; 2024 Jul; ():. PubMed ID: 39047052
    [No Abstract]   [Full Text] [Related]  

  • 37. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.
    Birenboim M; Chalupowicz D; Maurer D; Barel S; Chen Y; Fallik E; Paz-Kagan T; Rapaport T; Sadeh A; Kengisbuch D; Shimshoni JA
    Phytochemistry; 2022 Aug; 200():113215. PubMed ID: 35483556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palmitoylethanolamide: A Potential Alternative to Cannabidiol.
    Clayton P; Subah S; Venkatesh R; Hill M; Bogoda N
    J Diet Suppl; 2023; 20(3):505-530. PubMed ID: 34842030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.